Skip to main content
. 2026 Jul 22;27(14):6509. doi: 10.3390/ijms27146509
AC alcoholic cirrhosis
ACLF acute-on-chronic liver failure
AH alcohol-associated hepatitis
ALD alcohol-related liver disease
AUC area under the ROC curve
cACLD compensated advanced chronic liver disease
CSPH clinically significant portal hypertension
ELF Enhanced Liver Fibrosis test
eNAMPT extracellular nicotinamide phosphoribosyltransferase
FIB-4 Fibrosis-4 index
HOMA-IR homeostasis model assessment of insulin resistance
HVPG hepatic venous pressure gradient
iNAMPT intracellular nicotinamide phosphoribosyltransferase
MASLD metabolic dysfunction-associated steatotic liver disease
MetALD metabolic dysfunction and alcohol-related liver disease
NAFLD non-alcoholic fatty liver disease
NAMPT nicotinamide phosphoribosyltransferase
NOS Newcastle-Ottawa Scale
PBC primary biliary cholangitis
PEth phosphatidylethanol
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
RBP-4 retinol-binding protein 4
SLD steatotic liver disease
SWiM Synthesis Without Meta-Analysis
TLR4 Toll-like receptor 4